Search

everythinglearnresearchcommunity

for

Search:↓

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive stomach cancer.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Glibenclamide slows breast cancer cell growth by stopping cell division.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Metyrapone can effectively treat Cushing's Disease even if the mass causing it is not found.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Certain microRNAs found in normal cells can effectively suppress various cancers.

Plant compounds may offer a promising alternative for cancer treatment.